The following conclusions are derived from an epidemiological study. 927-930 (1997) 
Introduction
Human populations typically display a range of inherent sensitivities to radiation and chemical carcinogens. Such variability in host response may be due in part to inherent differences between individual ability to monitor and repair damaged sites induced in their genetic material by exogenous and endogenous genotoxic agents. A human model supporting such an assumption exists with the rare, cancer-prone inherited disorder xeroderma pigmentosum (XP) (1, 2) . XP patients experience a greater than 1000-fold excess frequency of sunlight-related skin cancers. Coupled to this marked susceptibility is the consistent laboratory finding that all cells tested from XP patients are defective in repairing DNA damage induced by ultraviolet (UV) radiation and other UV-mimetic agents. Because the UV component of solar radiation exists as the predominant environmental risk factor for skin cancer, a causal association between UV exposure, defective repair of UV-induced DNA photoproducts, and skin cancer is inferred. The link is further strengthened by clinical reports showing that the occurrence of skin tumors is practically ameliorated in XP patients afforded early and lifelong protection from sunlight exposure (3, 4) .
Taken together, these observations show that DNA The extent to which this hypothesis may be evaluated is dependent on the availability of validated laboratory methodology with which to measure DNA repair proficiency within study populations of interest. Such laboratory methodology has been developed and validated with over 450 subjects in case-control studies.
Methods and Results
T-lymphocytes isolated from subjects' peripheral blood were assayed (Figure 1 ) for their DRC (5 Age Stratification
The DRC of the subjects declined with age over the 20-to 60-year span studied (6). This age-related decline (apoptosis) occurred in both cases and controls, although it only reached significant decline in the controls (Figure 3 ). In the 106 controls, lacking any family history of skin cancer or presence of any premalignant skin lesions, the decline is 0.63% per year between 20 and 60 years of age. This would amount to about a 25% decrease in cumulative DRC over a 40-year period. This age-related decline in DNA repair should be accompanied by an increased accumulation of persistent DNA damage affecting an increase in mutation fixation in structural and functional proteins. The mutation rate accompanying aging in the hprt gene in human lymphocytes is reportedly between 1.3 and 1.6% per year (7), twice the rate of decline of DNA repair reported here. Many known genetically linked repair-deficiency diseases, such as Cockayne's syndrome and XP, also manifest premature aging (8) . In XP patients, the defect in DRC is associated with age-related skin changes and development of skin cancer 20 years earlier than in the normal population (2 
Multiplicity of Tumors
Multiple linear regression models were used (Figure 4) Basal cell carcinoma tumors, no. ratio was used to describe the risk of BCCs. and who have reduced repair capacity. These results agree with those obtained in the previous pilot study (5, 6) The persistence of UV-induced photoproducts, attributed to reduced DNA repair, was also studied at the level of p53 genes in BCC (12) . We analyzed 36 BCCs for p53 mutations and a subset of these tumors for loss of chromosomes 17p and 9q. Sixty-nine percent of the BCCs had lost a 9q allele, with the common area of loss surrounding the putative gene for nevoid BCC, or Gorlin's syndrome. Fortyfour percent (16 of 36) of BCCs had a mutated p53 allele, usually opposite pyrimidine tracts, which is consistent with UVinduced pyrimidine dimer and 6-4 adduct generated mutations. Surprisingly, only one tumor lost a 17p allele, and in all BCCs only one p53 allele was inactivated. This is in direct contrast to other epithelial tumors, which usually progress by the inactivation of both p53 alleles. It is possible that the absence of clinical progression of BCC may be related to the lack of complete p53 inactivation in these tumors. Condusions
The sunlight-BCC paradigm exemplifies the causal relationship between a specific kind of damage and the potential effects of the persistence of such damage in tumor progression; it also provides mechanistic insights into fundamental biological processes. These studies open doors for detailed examination of other forms of chromosomal instability in familial chronic diseases. Because the plasmid used in this DRC assay is a useful target for a large array of DNA-damaging agents it is feasible to extend these studies to a wide variety of diseases with potential genetic linkages. The only DNA damaging agents, in which this assay is not useful, however, are those that generate single-and double-strand breaks, since only supercoiled DNA is expressed in this assay system. Many repair deficiency diseases, such as XP, are associated with neurodegenerative symptoms, suggesting relationships between repair and chronic diseases other than cancer. Certainly the age relatedness of many cancers may be a characteristic of deficient DRC or mismatch repair. Defective or deficient repair processes associated with aging require that population and case-control studies involving repair assure that agematching is incorporated into study protocols. Further, it will be of great interest to determine which steps in the progression of DRC or mismatch repair are rate limiting, and to correlate organ specificity of a disease with specific steps in repair processes.
